Novonate
Palo Alto, US · Founded 2017 · Delaware corporation · 1 known investors
Find your way into Novonate
Founders & leadership
Novonate was founded in 2017 by Eric Chehab.
Investors · 1
Reported raises · per SEC filings
Form D private placements$624.7K disclosed across 1 round · 2017
▶$624.7KraisedDec 2017 · 3 investors · OtherRule 506(b)
▶$624.7KraisedDec 2017 · 3 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Radu CautisDirector
- Eric Fayez ChehabExecutive Officer, Director
- James WallDirector
- Offering amount
- $1.1M
- Amount sold
- $624.7K
- First sale
- Nov 2017
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Science Foundation | Phase I | 2021 | $256K |
| National Science Foundation | Phase I | 2017 | $225K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- Who founded Novonate?
- Novonate was founded by Eric Chehab in 2017.
- Who are Novonate's investors?
- Novonate's investors include Medical Technology Venture Partners.
- How much funding has Novonate raised?
- Novonate has disclosed $624.7K raised across 1 round.
- Where is Novonate headquartered?
- Novonate is headquartered in Palo Alto, US.